Gorbunova V A, Trofimova N B, Manziuk L V
Vopr Onkol. 1990;36(4):455-7.
Platinum-based combination chemotherapy regimens (CAP or CMF + cisplatin) were used for the treatment of disseminated breast cancer. Response rate for the CAP regimen was 47.5%. The most frequent side-effects were nausea, vomiting, nephrotoxicity and myelosuppression. Relationship between survival and response was identified.
铂类联合化疗方案(CAP或CMF+顺铂)用于治疗转移性乳腺癌。CAP方案的有效率为47.5%。最常见的副作用是恶心、呕吐、肾毒性和骨髓抑制。确定了生存率与疗效之间的关系。